MedTrace Logo

Epidemiological and Clinical Characteristics of Mpox Outbreak in Equateur, the DR Congo (Part1)

NCT07055867 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 122

Last updated 2025-07-09

No results posted yet for this study

Summary

The goal of this observational study is to characterize the clinical features of the 2024 mpox outbreak in Equateur Province of DRC and to identify associated risk factors. The main question it aims to answer is:

* What are the clinical features of the 2024 mpox outbreak in Equateur Province of DRC?
* What are the associated risk factors of the 2024 mpox outbreak? Participants which has mpox like symptoms will answer mpox investigations related questions and be collected skin lesions and whole blood samples.

Conditions

  • Mpox (Monkeypox)

Sponsors & Collaborators

  • Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo

    collaborator OTHER

  • Osaka Metropolitan University

    lead OTHER

Principal Investigators

  • Yasutoshi Kido, Professor · Osaka Metropolitan Unievrsity

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Democratic Republic of the Congo

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07055867 on ClinicalTrials.gov